Comparison of the Distribution and Changes in the Antibiotic Resistance of Clinical Bacterial Isolates from the Lower Respiratory Tract of Children in Shenzhen Before the Epidemic, During the Epidemic, and During the Period of Normalized Prevention and Control of COVID-19

[1]  Yuejie Zheng,et al.  Comparison of 11 respiratory pathogens among hospitalized children before and during the COVID-19 epidemic in Shenzhen, China , 2021, Virology journal.

[2]  Budi R. Permana,et al.  Genomic surveillance, characterization and intervention of a polymicrobial multidrug-resistant outbreak in critical care , 2021, Microbial genomics.

[3]  Eun Sug Park,et al.  Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[4]  Antibiotic resistance threats in the United States, 2019 , 2019 .

[5]  F. Hu,et al.  Resistance reported from China antimicrobial surveillance network (CHINET) in 2018 , 2019, European Journal of Clinical Microbiology & Infectious Diseases.

[6]  J. Rello,et al.  Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study , 2016, European Journal of Clinical Microbiology & Infectious Diseases.

[7]  E. de Jonge,et al.  An integrated approach to control a prolonged outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[8]  A. van Belkum,et al.  bro {beta}-lactamase and antibiotic resistances in a global cross-sectional study of Moraxella catarrhalis from children and adults. , 2010, The Journal of antimicrobial chemotherapy.

[9]  M. Jacobs,et al.  Antimicrobial Resistance in Haemophilus influenzae , 2007, Clinical Microbiology Reviews.

[10]  Samir N. Patel,et al.  Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline , 2006 .

[11]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[12]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .

[13]  C. Needham,et al.  Haemophilus influenzae: antibiotic susceptibility , 1988, Clinical Microbiology Reviews.

[14]  R. Jones,et al.  In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination , 1987, Journal of clinical microbiology.